Get the Stockscreener App
0.00
100.00%
-7.04
180 Life Sciences Corp stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.
See More
Previous Close:
$7.04
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$1.08B
Revenue:
-
Net Income/Loss:
$-3.12M
P/E Ratio:
0.00
EPS:
-4.8149
Net Cash Flow:
$-2.69M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$17.46
180 Life Sciences Corp Stock (ATNF) Company Profile
Name
180 Life Sciences Corp
Sector
Industry
Phone
650-507-0669
Address
3000 EL CAMINO REAL, PALO ALTO
Compare ATNF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATNF
180 Life Sciences Corp
|
0.00 | 1.08B | 0 | -3.12M | -2.69M | -4.8149 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.00 | 108.28B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
761.45 | 79.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.23 | 57.65B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
906.74 | 56.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
206.93 | 42.39B | 447.02M | -1.18B | -906.14M | -6.1812 |
180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-15-21 | Initiated | Maxim Group | Buy |
180 Life Sciences Corp Stock (ATNF) Latest News
180 Life Sciences Corp Stock Analysis and ForecastREITs Market Trends & Small Entry Trading Portfolio - earlytimes.in
How 180 Life Sciences Corp. Equity Warrant stock performs after earningsTrade Analysis Summary & Safe Capital Allocation Plans - newser.com
Why 180 Life Sciences Corp. Equity Warrant stock remains resilient2025 Earnings Surprises & Safe Swing Trade Setup Alerts - newser.com
How 180 Life Sciences Corp. stock benefits from global expansionJuly 2025 Selloffs & Risk Managed Investment Signals - newser.com
Why analysts upgrade 180 Life Sciences Corp. stock2025 Valuation Update & Trade Opportunity Analysis Reports - newser.com
Custom strategy builders for tracking 180 Life Sciences Corp. Equity WarrantEarnings Recap Summary & Reliable Price Action Trade Plans - newser.com
Can 180 Life Sciences Corp. stock sustain revenue growthMarket Weekly Review & High Conviction Buy Zone Picks - newser.com
Is 180 Life Sciences Corp. stock supported by strong fundamentalsMarket Growth Review & AI Driven Price Forecasts - newser.com
What is the fair value of 180 Life Sciences Corp. stock now2025 Valuation Update & Daily Chart Pattern Signals - newser.com
Can 180 Life Sciences Corp. Equity Warrant stock maintain growth trajectoryTrade Performance Summary & Verified Swing Trading Watchlists - newser.com
Can volume confirm reversal in 180 Life Sciences Corp. Equity WarrantQuarterly Trade Summary & Fast Entry High Yield Tips - newser.com
What insider trading reveals about 180 Life Sciences Corp. stockJuly 2025 Drop Watch & Comprehensive Market Scan Insights - newser.com
Short interest data insights for 180 Life Sciences Corp.2025 AllTime Highs & Smart Allocation Stock Tips - newser.com
What dividend safety score for 180 Life Sciences Corp. stock2025 Buyback Activity & Daily Profit Focused Screening - newser.com
Why 180 Life Sciences Corp. Equity Warrant stock could outperform in 2025Portfolio Value Summary & Low Risk High Reward Trade Ideas - newser.com
Custom watchlist performance reports with 180 Life Sciences Corp.Market Growth Report & High Conviction Investment Ideas - newser.com
Is this a good reentry point in 180 Life Sciences Corp.July 2025 Price Swings & Reliable Breakout Stock Forecasts - newser.com
Real time scanner hits for 180 Life Sciences Corp. explainedQuarterly Profit Review & Smart Allocation Stock Tips - newser.com
Will 180 Life Sciences Corp. stock continue upward momentum2025 Valuation Update & Fast Moving Stock Trade Plans - newser.com
How resilient is 180 Life Sciences Corp. stock in market downturns - newser.com
Leading vs lagging indicators on 180 Life Sciences Corp. Equity Warrant performanceAnalyst Downgrade & Weekly Watchlist for Hot Stocks - newser.com
180 Life Sciences Corp Stock (ATNF) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.13%
4.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):